IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,932,842 | -12.9% | 51,174 | +1.9% | 0.02% | -14.3% |
| Q3 2022 | $2,220,000 | -39.5% | 50,199 | -49.4% | 0.03% | -31.7% |
| Q2 2022 | $3,670,000 | -0.1% | 99,129 | 0.0% | 0.04% | +13.9% |
| Q1 2022 | $3,672,000 | +41.8% | 99,129 | +16.5% | 0.04% | +44.0% |
| Q4 2021 | $2,590,000 | +102.5% | 85,103 | +123.2% | 0.02% | +92.3% |
| Q3 2021 | $1,279,000 | -14.7% | 38,132 | +1.4% | 0.01% | -13.3% |
| Q2 2021 | $1,500,000 | -11.2% | 37,600 | 0.0% | 0.02% | -16.7% |
| Q1 2021 | $1,690,000 | -20.5% | 37,600 | 0.0% | 0.02% | -21.7% |
| Q4 2020 | $2,126,000 | +19.2% | 37,600 | 0.0% | 0.02% | +9.5% |
| Q3 2020 | $1,784,000 | -19.5% | 37,600 | 0.0% | 0.02% | -19.2% |
| Q2 2020 | $2,217,000 | -38.7% | 37,600 | -50.8% | 0.03% | -40.9% |
| Q1 2020 | $3,616,000 | +53.6% | 76,476 | +96.3% | 0.04% | +91.3% |
| Q4 2019 | $2,354,000 | -7.0% | 38,963 | -7.8% | 0.02% | -11.5% |
| Q3 2019 | $2,531,000 | -5.0% | 42,246 | +1.9% | 0.03% | +8.3% |
| Q2 2019 | $2,664,000 | – | 41,443 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |